|
1 |
Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho
Endocrinol Metab.2023;38(1):1-9. Published online 2023 February 13
DOI: http://dx.doi.org/10.3803/EnM.2023.103
|
|
2 |
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond
Adie Viljoen, Stephen C. Bain
Endocrinol Metab.2023;38(1):25-33. Published online 2023 February 6
DOI: http://dx.doi.org/10.3803/EnM.2022.1642
|
|
3 |
DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
Youjin Kim, Si Woo Lee, Hyejin Wang, Ryeong-Hyeon Kim, Hyun Ki Park, Hangkyu Lee, Eun Seok Kang
Diabetes Metab J.2022;46(2):337-348. Published online 2022 January 21
DOI: http://dx.doi.org/10.4093/dmj.2021.0056
|
|
4 |
Recent Updates on Glucagon-Like Peptide 1 Receptor Agonist
Hae Jin Kim
|
|
5 |
Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials
Shinje Moon, Jibeom Lee, Hye Soo Chung, Yoon Jung Kim, Jae Myung Yu, Sung Hoon Yu, Chang-Myung Oh
Endocrinol Metab.2021;36(3):647-660. Published online 2021 June 18
DOI: http://dx.doi.org/10.3803/EnM.2020.934
|
|
6 |
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Endocrinol Metab.2021;36(1):157-170. Published online 2021 February 24
DOI: http://dx.doi.org/10.3803/EnM.2020.781
|
|
7 |
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Hun Jee Choe, Young Min Cho
Endocrinol Metab.2021;36(1):22-29. Published online 2021 February 24
DOI: http://dx.doi.org/10.3803/EnM.2021.102
|
|
8 |
Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
Jae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Cho
Diabetes Metab J.2020;44(2):248-259. Published online 2019 November 4
DOI: http://dx.doi.org/10.4093/dmj.2019.0018
|
|
9 |
Saxenda® Frenzy: Opinions of an Endocrine and Metabolism Specialist
Sungrae Kim
|
|
10 |
Premeal Consumption of a Protein-Enriched, Dietary Fiber-Fortified Bar Decreases Total Energy Intake in Healthy Individuals
Chang Ho Ahn, Jae Hyun Bae, Young Min Cho
|
|
11 |
Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
Soyeon Yoo, Eun-Jin Yang, Gwanpyo Koh
Diabetes Metab J.2019;43(4):495-503. Published online 2019 February 20
DOI: http://dx.doi.org/10.4093/dmj.2018.0105
|
|
12 |
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
Hyeonhui Kim, Sungsoon Fang
Lab Anim Res.2018;34(4):140-146. Published online 2018 December 31
DOI: http://dx.doi.org/10.5625/lar.2018.34.4.140
|
|
13 |
Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
Yu Mi Kang, Yun Kyung Cho, Jiwoo Lee, Seung Eun Lee, Woo Je Lee, Joong-Yeol Park, Ye-Jee Kim, Chang Hee Jung, Michael A. Nauck
Diabetes Metab J.2019;43(4):410-421. Published online 2018 December 27
DOI: http://dx.doi.org/10.4093/dmj.2018.0070
|
|
14 |
Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab.2017;32(3):316-325. Published online 2017 September 18
DOI: http://dx.doi.org/10.3803/EnM.2017.32.3.316
|
|
15 |
Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
Sang Ah Lee, Gwanpyo Koh, Suk Ju Cho, So-Yeon Yoo, Sang Ouk Chin
Endocrinol Metab.2016;31(3):439-445. Published online 2016 September 26
DOI: http://dx.doi.org/10.3803/EnM.2016.31.3.439
|
|
16 |
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
|
|
17 |
Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus
Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim, Kyu Yeon Hur, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee
|
|
18 |
Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion
Eun Ky Kim, Tae Jung Oh, Lee-Kyung Kim, Young Min Cho
|
|
19 |
Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes
Hye Min Lee, Bo Sun Joo, Chang Hoon Lee, Heung Yeol Kim, Ji Hoon Ock, Young Seok Lee
|
|
20 |
Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
Se Hee Min, Young Min Cho
|
|